Low Level Laser Therapy Versus Pharmacotherapy in Improving Myofascial Pain Disorder Syndrome
Journal of Lasers in Medical Sciences,
Vol. 7 No. 1 (2016),
26 January 2016
Introduction: Temporomandibular disorders (TMD) lead to masticatory muscle pain, jaw movement disability and limitation in mouth opening. Pain is the chief complaint in 90% of the TMD patients which leads to disability and severe socioeconomic costs. The purpose of this study was to evaluate the therapeutic effects of low level laser therapy (LLLT) compared to pharmacotherapy with NSAIDs (naproxen) in myofascial pain disorder syndrome (MPDS).
Methods: In this randomized controlled clinical trial, 40 MPDS patients were divided into two groups. One group received naproxen 500 mg bid for 3 weeks as treatment modality and also had placebo laser sessions. The other group received active laser (diode 810 nm CW) as treatment and placebo drug. Pain intensity was measured by visual analogue scale (VAS) and maximum painless mouth opening was also measured as a functional index every session and at 2 months follow up. Data was collected and analyzed with SPSS software. Independent t test was used to analyze the data. A P < 0.05 was considered significant.
Results: Low level laser caused significant reduction in pain intensity (P < 0.05) and a significant increase in mouth opening. In naproxen group neither pain intensity nor maximum mouth opening had significant improvement. Pain relief, in subjective VAS was observed in third session in LLLT group, but did not occur in naproxen group. Maximum mouth opening increased significantly in laser group compared to the naproxen group from the eighth session.
Conclusion: Treatment with LLLT caused a significant improvement in mouth opening and pain intensity in patients with MPDS. Similar improvement was not observed in naproxen group.
- Myofascial pain disorder syndrome
- Laser therapy
How to Cite
Manfredini D, Guarda-Nardini L, Winocur E. Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 112(4):453-462. doi:10.1016/j.tripleo.2011.04.021.
Barbosa TS, Leme MS, Castelo PM. Evaluating oral health-related quality of life measure for children and preadolescents with temporomandibular disorder. Health Qual Life Outcomes. 2011;12:9-32. doi:10.1186/1477-7525- 9-32.
Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med. 2008; 359:2693-705.
Argoff CE. Pharmacologic management of chronic pain. J Am Osteopath Assoc. 2002;102:S21-S217. doi:10.3344/ kjp.2010.23.2.99.
Cairns BE. Pathophysiology of TMD pain--basic mechanisms and their implications for pharmacotherapy. J Oral Rehabil. 2010; 37:391-410. doi:10.1111/j.1365- 2842.2010.02074.x.
Ta LE, Dionne RA. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen. Pain. 2004;111(1-2):13-21.
Greenberg M, Glick M, Ship J. Burkett’s Oral Medicine.11th ed. BC Decker Inc; 2008:235-246.
Ahrari F, Madani AS. The efficacy of low-level laser therapy for the treatment of myogenous temporomandibular joint disorder. Lasers Med Sci. 2014;29(2):551-557. doi:10.1007/ s10103-012-1253-6.
Salmos-Brito JA, Menezes RF. Evaluation of low-level laser therapy in patients with acute and chronic temporomandibular disorders. Lasers Med Sci. 2013;28(1):57-64. doi:10.1007/s10103-012-1065-8.
Marini I, Gatto MR, Bonetti GA. Effects of superpulsed low-level laser therapy on temporomandibular joint pain. Clin J Pain. 2010; 26(7):611-6. doi:10.1097/ AJP.0b013e3181e0190d.
Mazzetto MO, Hotta TH, Pizzo RC. Measurements of jaw movements and TMJ pain intensity in patients treated with GaAlAs laser. Braz Dent. 2010;21(4):356-360.
Shirani AM, Gutknecht N, Taghizadeh M. Low-level laser therapy and myofacial pain dysfunction syndrome: a randomized controlled clinical trial. Lasers Med Sci. 2009;24:715-720. doi:10.1007/s10103-008-0624-5.
Carrasco TG, Guerisoli LD, Guerisoli DM. Evaluation of low intensity laser therapy in myofascial pain syndrome. Cranio. 2009;27:243-247.
Emshoff R, Bösch R, Pümpel E. Low-level laser therapy for treatment of temporomandibular joint pain: a double-blind and placebo-controlled trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:452-456. doi:10.1016/j. tripleo.2007.09.012.
Hode TJ. Clinical practice and scientific background. Tallinn, Estonia: Prima Books; 2002.
Seres JL. The fallacy of using 50% pain relief as the standard for satisfactory pain treatment outcome, J Pain. 1999;8:183-188 .
Okeson JP. Management of temporomandibular disorder and occlusion. 6th ed. St Louis: Mosby; 2008:2-375.
Martins-Júnior RL, Palma AJ, Marquardt EJ, Gondin TM, Kerber Fde C. Temporomandibular disorders: a report of 124 patients. J Contemp Dent Pract. 2010;14:071-078 .
Mortazavi H, Javadzadeh A, Delavarian Z, Zare Mahmoodabadi R. Myofascial Pain Dysfunction Syndrome. Iranian J Otorhinolaryngol. 2010;22:61.
Lipton JA, Ship JA, Larch-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc. 1993;124:115-121.
Glass EG, Glaros AG. Health service research on TMD. In: Sessle BJ, Bryant PS, Dionne RA, editors. Temporomandibular disorder and related pain conditions. Progress in pain research and management. Seattle: IASP; 1995:249-254
Minghelli B, Cardoso I, Porfírio M, et al. Prevalence of temporomandibular disorder in children and adolescents from public schools in southern Portugal. N Am J Med Sci. 2014,6(3):126-132.
Hsieh YL, Chou LW, Chang PL. Low-level laser therapy alleviates neuropathic pain and promotes function recovery in rats with chronic constriction injury-possible involvements in hypoxia-inducible factor 1alpha (HIF- 1alpha). J Comp Neurol. 2012;520(13):2903-2916. doi:10.1002/cne.23072.
Marcos RL, Leal Junior EC, Messias Fde M. Infrared (810 nm) low-level laser therapy in rat Achilles tendinitis: a consistent alternative to drugs. Photochem Photobiol. 2011;87(6):1447-1452.
da Cunha LA, Firoozmand LM, da Silva AP. Efficacy of low-level laser therapy in the treatment of temporomandibular disorder. Int Dent J. 2008;58:213-7.
Herranz-Aparicio J, Vázquez-Delgado E, Arnabat- Domínguez J, España-Tost A, Gay-Escoda C. The use of low level laser therapy in the treatment of temporomandibular joint disorders. Review of the literature. Med Oral Patol Oral Cir Bucal. 2013;18(4):e603-e612.
Melis M, Di Giosia M, Zawawi KH. Low level laser therapy for the treatment of temporomandibular disorders: A systematic review of the literature. Cranio. 2012;30:304- 312.
- Abstract Viewed: 910 times
- PDF Downloaded: 372 times